Liberty Military Housing Regional Vice President, Daniel 28-02-2023, 21:10

Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability 3-09-2024, 19:00

Founder Group Limited to Significantly Benefit From up to RM17.4 billion [USD4.1 billion] Solar EPCC Contract Value Expected to Ignite Green Energy, Data Center Expansion and National AI Ambitions in Malaysia 24-09-2025, 19:30